Cited by 645Dietary Effects on HealthNutritional Studies and DietDiet and metabolism studies

Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial

Open access
Trepanowski, John F., Kroeger, Cynthia M., Barnosky, Adrienne, Klempel, Monica C., Bhutani, Surabhi, Hoddy, Kristin K., Gabel, Kelsey, Freels, Sally +4 more·2017·JAMA Internal Medicine

Abstract

Importance: Alternate-day fasting has become increasingly popular, yet, to date, no long-term randomized clinical trials have evaluated its efficacy. Objective: To compare the effects of alternate-day fasting vs daily calorie restriction on weight loss, weight maintenance, and risk indicators for cardiovascular disease. Design, Setting, and Participants: A single-center randomized clinical trial of obese adults (18 to 64 years of age; mean body mass index, 34) was conducted between October 1, 2011, and January 15, 2015, at an academic institution in Chicago, Illinois. Interventions: Participants were randomized to 1 of 3 groups for 1 year: alternate-day fasting (25% of energy needs on fast days; 125% of energy needs on alternating "feast days"), calorie restriction (75% of energy needs every day), or a no-intervention control. The trial involved a 6-month weight-loss phase followed by a 6-month weight-maintenance phase. Main Outcomes and Measures: The primary outcome was change in body weight. Secondary outcomes were adherence to the dietary intervention and risk indicators for cardiovascular disease. Results: Among the 100 participants (86 women and 14 men; mean [SD] age, 44 [11] years), the dropout rate was highest in the alternate-day fasting group (13 of 34 [38%]), vs the daily calorie restriction group (10 of 35 [29%]) and control group (8 of 31 [26%]). Mean weight loss was similar for participants in the alternate-day fasting group and those in the daily calorie restriction group at month 6 (-6.8% [95% CI, -9.1% to -4.5%] vs -6.8% [95% CI, -9.1% to -4.6%]) and month 12 (-6.0% [95% CI, -8.5% to -3.6%] vs -5.3% [95% CI, -7.6% to -3.0%]) relative to those in the control group. Participants in the alternate-day fasting group ate more than prescribed on fast days, and less than prescribed on feast days, while those in the daily calorie restriction group generally met their prescribed energy goals. There were no significant differences between the intervention groups in blood pressure, heart rate, triglycerides, fasting glucose, fasting insulin, insulin resistance, C-reactive protein, or homocysteine concentrations at month 6 or 12. Mean high-density lipoprotein cholesterol levels at month 6 significantly increased among the participants in the alternate-day fasting group (6.2 mg/dL [95% CI, 0.1-12.4 mg/dL]), but not at month 12 (1.0 mg/dL [95% CI, -5.9 to 7.8 mg/dL]), relative to those in the daily calorie restriction group. Mean low-density lipoprotein cholesterol levels were significantly elevated by month 12 among the participants in the alternate-day fasting group (11.5 mg/dL [95% CI, 1.9-21.1 mg/dL]) compared with those in the daily calorie restriction group. Conclusions and Relevance: Alternate-day fasting did not produce superior adherence, weight loss, weight maintenance, or cardioprotection vs daily calorie restriction. Trial Registration: clinicaltrials.gov Identifier: NCT00960505.

Verified 2026-10-05 · 1 reference not checked yet

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2017.0936

Cites

31 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 28 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Lean mass did not differ significantly between the alternate-day fasting and daily calorie restriction groups at month 6 or month 12.

    “There were no statistically significant differences between the alternate-day fasting group and the daily calorie restriction group for fat mass, lean mass, or visceral fat mass at month 6 or month 12.”
    Quote in the paperSubstantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Findingown data

    Heart rate did not differ significantly between the alternate-day fasting and daily calorie restriction groups at month 6 or month 12.

    “There were also no statistically significant differences in heart rate between the alternate-day fasting group and the daily calorie restriction group at month 6 or month 12 (Table 2).”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Findingown data

    Blood pressure did not differ significantly between the alternate-day fasting and daily calorie restriction groups at month 6 or month 12.

    “Blood pressure was not significantly different between the intervention groups, or relative to controls, at month 6 or month 12 (Table 2).”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Findingown data

    Total cholesterol did not differ significantly between the alternate-day fasting and daily calorie restriction groups at month 6 or month 12.

    “Total cholesterol levels were not significantly different between the intervention groups, or relative to controls, at month 6 or month 12.”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Findingown data

    Weight regain from months 6 to 12 did not differ significantly between the alternate-day fasting group and the control group.

    “Moreover, weight regain from months 6 to 12 was not significantly different between the alternate-day fasting group and controls (0.8%; 95% CI, −1.8% to 3.3%)”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Classified as probably not a substantial claim. 17
  • May combine two claims. 8
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    The daily calorie restriction group met its prescribed energy goals at months 3, 6, and 12 but ate less than prescribed at month 9.

    “Participants in the daily calorie restriction group (Figure 2C) met their prescribed energy goals at months 3, 6, and 12 but ate less than their prescribed goal at month 9.”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Participants had previously been sedentary.

    “who had previously been sedentary (<60 minutes per week of light activity for the 3 months prior to the study)”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    All participants were instructed not to change their physical activity habits during the trial to avoid potential confounding.

    “All participants were instructed not to change their physical activity habits throughout the trial (eg, not to join a gym) to avoid potential confounding.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductown data

    Tests for normality were included in the model, and all data were found to be normally distributed.

    “Tests for normality were included in the model, and all data were found to be normally distributed.”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Classified as probably not a substantial claim.

    Study design and conductreasoning

    The sample size calculation estimated that 26 participants per group would provide 80% power to detect a 5% difference in body weight at month 6.

    “We calculated that 26 participants per group would provide 80% power to detect a significant difference of 5% in body weight between the alternate-day fasting group and the daily calorie restriction group at month 6, using a 2-tailed independent-samples t test with α = .05.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The participants were primarily metabolically healthy obese women.

    “The participants were primarily metabolically healthy obese women.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    Visceral fat images were analyzed using validated software.

    “images were analyzed using validated software.20”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [20] Demerath EW Ritter KJ Couch WA Validity of a new automated software program for visceral adipose tissue estimation Int J Obes (Lond) 2007 31 2 285 291 16770332 PMC1783906

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    A sensitivity analysis including sex and race/ethnicity as covariates did not affect the estimated treatment effects.

    “We also performed a sensitivity analysis, in which sex and race/ethnicity were included as adjustment covariates in the intention-to-treat mixed model. The inclusion of sex and race/ethnicity did not affect any of the estimated treatment effects reported in Table 2.”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The mean body mass index of participants was 34.

    “mean body mass index, 34”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    The first-line therapy prescribed to obese patients for weight loss is daily calorie restriction.

    “The first-line therapy prescribed to obese patients for weight loss is daily calorie restriction.1”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [1] Jensen MD Ryan DH Apovian CM American College of Cardiology/American Heart Association, Task Force on Practice Guidelines; Obesity Society 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society Circulation 2014 129 25(suppl 2) S102 S138 24222017 PMC5819889

      Not checked in the free run.

  • May combine two claims.

    Study design and conductreasoning

    The control group was imperfect because it received no food, no counseling, and less attention from study personnel, which may have confounded the findings.

    “Second, the control group was imperfect, in that they received no food, no counseling, and less attention from study personnel, relative to the intervention groups, which may have confounded our findings.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Because many participants had normal cholesterol and blood pressure at baseline, it is not surprising that most cardiovascular risk indicators did not change with diet.

    “Since many of the participants had normal cholesterol levels and normal blood pressure at baseline, it is not surprising that most risk indicators for cardiovascular disease did not change in response to diet.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductnone given

    The protocol was approved by the Office for the Protection of Research Subjects, and written informed consent was obtained from all participants.

    “The protocol was approved by the Office for the Protection of Research Subjects at the University of Illinois at Chicago, and written informed consent was obtained from all participants.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The control group was not included in the initial power calculation.

    “We also failed to include the control group in our initial power calculation.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisenone given

    The present study is the longest and largest trial of alternate-day fasting to date.

    “To our knowledge, the present study is the longest and largest trial of alternate-day fasting to date.”
    Quote in the paperNot a substantial claim0 of 7 sources checked
    • cites [7] Bhutani S Klempel MC Kroeger CM Trepanowski JF Varady KA Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans Obesity (Silver Spring) 2013 21 7 1370 1379 23408502

      Not checked in the free run.

    • cites [8] Hoddy KK Kroeger CM Trepanowski JF Barnosky A Bhutani S Varady KA Meal timing during alternate day fasting: impact on body weight and cardiovascular disease risk in obese adults Obesity (Silver Spring) 2014 22 12 2524 2531 25251676

      Not checked in the free run.

    • cites [9] Johnson JB Summer W Cutler RG Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma [published correction appears in Free Radic Biol Med. 2007;43(9):1348] Free Radic Biol Med 2007 42 5 665 674 17291990 PMC1859864

      Not checked in the free run.

    • cites [10] Klempel MC Kroeger CM Varady KA Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet Metabolism 2013 62 1 137 143 22889512

      Not checked in the free run.

    • cites [11] Varady KA Bhutani S Church EC Klempel MC Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults Am J Clin Nutr 2009 90 5 1138 1143 19793855

      Not checked in the free run.

    • cites [12] Catenacci VA Pan Z Ostendorf D A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity Obesity (Silver Spring) 2016 24 9 1874 1883 27569118 PMC5042570

      Not checked in the free run.

    • cites [13] Alhamdan BA Garcia-Alvarez A Alzahrnai AH Alternate-day versus daily energy restriction diets: which is more effective for weight loss? a systematic review and meta-analysis Obes Sci Pract 2016 2 3 293 302 27708846 PMC5043510

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The trial used an intention-to-treat analysis that included all 100 randomized participants.

    “We conducted an intention-to-treat analysis, which included data from all 100 participants who underwent randomization.”
    Quote in the paperNot a substantial claim
    • The authors state this as an assumption: The missing data mechanism is missing at random.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The trial was registered at clinicaltrials.gov with identifier NCT00960505.

    “clinicaltrials.gov Identifier: NCT00960505”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductown data

    Participants were randomized in a 1:1:1 ratio to alternate-day fasting, daily calorie restriction, or control, with stratification by sex, age, and body mass index.

    “Participants were randomized in a 1:1:1 ratio to an alternate-day fasting group, daily calorie restriction group, or no-intervention control group. Randomization was performed by a stratified random sampling procedure by sex, age (18–42 years and 43–65 years), and body mass index (25.0–32.5 and 32.6–39.9).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Participants were aged 18 to 64 years.

    “obese adults (18 to 64 years of age; mean body mass index, 34)”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The maintenance phase duration was short (6 months).

    “First, the duration of the maintenance phase was short (6 months).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    Short-term studies indicate that participants lose 3% to 7% of body weight after 2 to 3 months of alternate-day fasting and experience improvements in lipid profiles, blood pressure, and insulin sensitivity.

    “Findings from short-term studies indicate that participants lose 3% to 7% of body weight after 2 to 3 months of alternate-day fasting and experience improvements in lipid profiles, blood pressure, and insulin sensitivity.7–13”
    Quote in the paperSubstantial claim0 of 7 sources checked
    • cites [7] Bhutani S Klempel MC Kroeger CM Trepanowski JF Varady KA Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans Obesity (Silver Spring) 2013 21 7 1370 1379 23408502

      Not checked in the free run.

    • cites [8] Hoddy KK Kroeger CM Trepanowski JF Barnosky A Bhutani S Varady KA Meal timing during alternate day fasting: impact on body weight and cardiovascular disease risk in obese adults Obesity (Silver Spring) 2014 22 12 2524 2531 25251676

      Not checked in the free run.

    • cites [9] Johnson JB Summer W Cutler RG Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma [published correction appears in Free Radic Biol Med. 2007;43(9):1348] Free Radic Biol Med 2007 42 5 665 674 17291990 PMC1859864

      Not checked in the free run.

    • cites [10] Klempel MC Kroeger CM Varady KA Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet Metabolism 2013 62 1 137 143 22889512

      Not checked in the free run.

    • cites [11] Varady KA Bhutani S Church EC Klempel MC Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults Am J Clin Nutr 2009 90 5 1138 1143 19793855

      Not checked in the free run.

    • cites [12] Catenacci VA Pan Z Ostendorf D A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity Obesity (Silver Spring) 2016 24 9 1874 1883 27569118 PMC5042570

      Not checked in the free run.

    • cites [13] Alhamdan BA Garcia-Alvarez A Alzahrnai AH Alternate-day versus daily energy restriction diets: which is more effective for weight loss? a systematic review and meta-analysis Obes Sci Pract 2016 2 3 293 302 27708846 PMC5043510

      Not checked in the free run.

21 of 21
  • The authors state this as an assumption.

    The missing data mechanism is missing at random.

    “This model provides unbiased estimates of time and treatment effects under a missing-at-random assumption.”
  • The paper relies on this without support.

    No long-term randomized clinical trials have evaluated the efficacy of alternate-day fasting or compared it with a conventional weight-loss diet.

    “Despite the growing popularity of alternate-day fasting, to our knowledge, no long-term randomized clinical trials have evaluated its efficacy or compared this regimen with a conventional weight-loss diet.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The superior weight loss in the INT group in the present study is in contrast with the majority of studies that have reported no advantage of intermittent over continuous ER.

    “The superior weight loss in the INT group in the present study is in contrast with the majority of studies that have reported no advantage of intermittent over continuous ER.”

    From Intermittent energy restriction improves weight loss efficiency in obese men: the MATADOR study (2018) · cites this paper as [42]

    The Results (Weight Loss and Weight Maintenance; page not available) report no significant weight-loss difference between alternate-day fasting and daily calorie restriction, so this study supports the cited comparison. As a single trial, it does not establish the claim that a majority of studies found no advantage. The citing authors’ finding of superior weight loss in their own INT group is not attributed to this source. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • This trend is consistent with Trepanowski et al.'s findings, which observed improvements in plasma lipids with ADF at 6 months.

    “This trend is consistent with Trepanowski et al.'s findings [74], which also observed improvements in plasma lipids with ADF at 6 months.”

    From Comparing caloric restriction regimens for effective weight management in adults: a systematic review and network meta-analysis (2024) · cites this paper as [74]

    The Results (Plasma Lipids) report a significant increase in HDL cholesterol with alternate-day fasting versus daily calorie restriction at month 6. They report no significant differences in total cholesterol, LDL cholesterol, or triglycerides at that time, so the broader claim of improvements in plasma lipids overstates the finding. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • A recent 12-month clinical trial and several recent reviews have concluded that existing models of intermittent ER (largely versions of intermittent fasting) could be considered equivalent, but not superior, alternatives for weight loss.

    “A recent 12-month clinical trial42 and several recent reviews9,43, 44 have concluded that existing models of intermittent ER (largely versions of intermittent fasting), could be considered equivalent, but not superior, alternatives for weight loss.”
  • In a 12-month study, ADF (25% of daily energy needs on fasting days: one day on, one day off) compared with a calorie-restricted (75% of energy needs every day) and a control diet resulted in weight loss in the two intervention groups, but insulin sensitivity, blood lipid levels and blood glucose were not improved.

    “It was demonstrated that although the two intervention groups lost weight, insulin sensitivity, blood lipid levels and blood glucose were not improved.”
  • A few studies have extended up to 52 weeks and show similar findings on intermittent fasting and weight loss.

    “A few studies have extended up to 52 weeks and show similar findings (152-155).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

  • Trial phases total 13 months, not one year

    Minor

    The stated baseline, weight-loss, and maintenance phases add up to 13 months, although the active trial duration is described as one year (12 months).

    Reported 12 · recomputed 13

1 of 1

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [15]The 5:2 Fast Diet For Beginners Berkeley, CA Rockridge Press 2013

Cited by

Sorted by citations

Authors
Trepanowski, J. F., Kroeger, C. M., Barnosky, A., Klempel, M. C., Bhutani, S., Hoddy, K. K., Gabel, K., Freels, S., Rigdon, J., Rood, J., Ravussin, E., & Varady, K. A.
Affiliations
  • University of Illinois Chicago (US)
  • University of Alabama at Birmingham (US)
  • Stanford University (US)
  • Pennington Biomedical Research Center (US)
  • Nutrition Obesity Research Center, Pennington Biomedical Research Center, Baton Rouge, Louisiana
Corresponding author
Varady, Krista A.
Venue
JAMA Internal Medicine
Published
2017-07-01
Volume
177
Issue
7
Pages
930
ISSN
2168-6106 (ISSN-L)
OpenAlex
W2611504779
Cited by
645
References
32
Citations by year
2026: 45 · 2025: 71 · 2024: 76 · 2023: 95 · 2022: 103 · 2021: 90 · 2020: 81 · 2019: 35 · 2018: 38 · 2017: 10 · 2016: 1
FWCI
33.20
Type
journal article
Language
en
Open access
Locations
  • JAMA Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL106228)
  • National Institute of Diabetes and Digestive and Kidney Diseases (F32DK107157, P30DK072476)
Topics
  • Health Sciences › Medicine › Physiology › Dietary Effects on Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Physiology › Diet and metabolism studies
Keywords
alternate-day fasting, caloric restriction, weight loss, weight maintenance, metabolically healthy obesity, cardiovascular risk factors, cardioprotection, dietary adherence, blood pressure, insulin resistance, fasting blood glucose, triglycerides, long-term weight management, heart rate, blood pressure variability, heart rate variability
MeSH terms
Adult, Blood Glucose, Cardiovascular Diseases, Diet Therapy, Fasting, Feeding Behavior, Female, Humans, Insulin, Male, Middle Aged, Obesity, Outcome and Process Assessment, Health Care, Patient Compliance, Risk Factors, Weight Loss, Caloric Restriction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review